Tower Research Capital (TRC)’s Molecular Partners MOLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MOLN
Tower Research Capital (TRC)'s MOLN Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Molecular Partners (MOLN) in Q3 2026: 45 shares worth $176. The stake represents ﹤0.01% of the portfolio and ranks #5693 among its holdings.
7 funds tracked by Wall St. Rank hold MOLN as of Q3 2026.
- Tower Research Capital (TRC) held 45 shares of Molecular Partners worth $176 as of Q3 2026.
- Molecular Partners was a new Tower Research Capital (TRC) position in Q3 2026.
- Molecular Partners made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5693 holding.
- 7 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.